Practice question

Answer the question and get instant feedback.

MediumEndocrinologyPeripheral Artery Disease with Diabetesus-abfmus-usmle-step-2us-usmle-step-3

A 68-year-old woman with diabetes and CKD G3a has A1c 7.6% on metformin and SGLT2 inhibitor. Which second-line glucose-lowering class has CV benefit in PAD per 2024 PAD guideline?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.